ENVERIC BIOSCIENCES, INC. Accounts Payable
ENVERIC BIOSCIENCES, INC. (ENVB) had Accounts Payable of $682.79 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $682.79K.
- 2026-03-31: Accounts Payable, Current $280.31K.
- 2025-12-31: Accounts Payable, Current $581.02K.
- 2025-09-30: Accounts Payable, Current $683.71K.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $682.79K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $280.31K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $581.02K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $683.71K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.04M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $669.19K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $521.75K 10-K · filed 2026-03-27 | |
| 2024-09-30 | $576.32K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $459.90K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $1.85M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.22M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $1.10M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.23M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $1.79M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $463.27K 10-K · filed 2024-03-26 | |
| 2022-09-30 | $710.31K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $754.30K 10-Q · filed 2022-08-12 | |
| 2021-12-31 | $683.39K 10-K/A · filed 2023-06-09 | |
| 2020-09-30 | $4.58M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $4.87M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $5.25M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $4.70M 10-Q · filed 2020-11-16 | |
| 2019-09-30 | $4.71M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $4.95M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $5.08M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $4.38M 10-K/A · filed 2020-08-12 | |
| 2018-09-30 | $4.22M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $4.87M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $5.32M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $5.32M 10-K · filed 2019-03-26 | |
| 2017-09-30 | $4.13M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $3.95M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $4.47M 10-Q/A · filed 2017-05-15 | |
| 2016-12-31 | $5.13M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $4.91M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $3.22M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $2.59M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $2.60M 10-K/A · filed 2017-04-04 | $2.60M 10-KT · filed 2016-03-15 |
| 2015-09-30 | $3.56M 10-Q · filed 2015-11-23 | |
| 2015-06-30 | $3.43M 10-Q · filed 2015-08-18 | |
| 2015-03-31 | $2.92M 10-KT · filed 2016-03-15 | $2.94M 10-Q · filed 2015-08-17 |
| 2014-03-31 | $2.80M 10-KT · filed 2016-03-15 | |
| 2011-09-30 | $7.70K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $7.70K 10-Q · filed 2011-08-02 | |
| 2010-12-31 | $2.64K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |